Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases (Q36164238)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases |
scientific article |
Statements
1 reference
Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases. (English)
1 reference
Peter Lundh von Leithner
Richard Foxton
Veluchamy A Barathi
Chui Ming Gemmy Cheung
Sai Bo Bo Tun
Yeo Sia Wey
Daiju Iwata
Miroslav Dostalek
Jörg Moelleken
Kay G Stubenrauch
Everson Nogoceke
Gabriella Widmer
Pamela Strassburger
Michael J Koss
Christian Klein
14 October 2016
1 reference
1 reference